Home > PS Ratio > SANOFI INDIA

SANOFI INDIA
PS (Price/Sales) Ratio

The Current P/S Ratio of SANOFI INDIA is 6.04.

Share Price ₹5,870.0Apr 02,2025
Market Cap ₹13,500.9 Cr
Sales-TTM₹2,234.8 CrTTM-Standalone Results
Price/Sales6.04xCalculated as Market Cap/Sales
Explore Stock Analytics
COMMUNITY POLL
for SANOFI INDIA
Please provide your vote to see the results
SANOFI INDIA is part of below Screeners ↓
Top Small Cap Stocks with Best Fundamentals
Best Quarterly Growth Small Cap Stocks
Best 1M Momentum Small Cap Stocks

Definition & Calculation of PS (Price/Sales) ratio of SANOFI INDIA

Price-to-Sales ratio, P/S Multiple, or P/S Ratio is an important valuation multiple that is defined as:

P/S = Market Capitalization / Sales

or, using per-share numbers:

P/S = Stock Price / Sales Per Share

Applying the above formula, P/S ratio of SANOFI INDIA is calculated as :

Current Market Cap [ ₹13,500.9 Cr] as on Apr 02,2025

(/) Sales [ ₹2,234.8 Cr] based on TTM-Standalone Results

(=) P/S Ratio [ 6.04x ]

P/S Ratio indicates 'the multiple of sales' investors are willing to pay to own one share of the company.

Thus, for SANOFI INDIA , the investors are currently willing to pay '6.04 times sales' to own 1 share of the company.

PS Multiples are one of the most widely used valuation multiple in the industry.

P/S ratios can be a reliable benchmark to compare companies with negative earnings or book value.

You may also explore Price to Earnings ratio or Price to Book ratio of SANOFI INDIA !

The chart below summarizes the trend in P/S Ratio of SANOFI INDIA over the last five years.

Historical PS (Price/Sales) ratio chart of SANOFI INDIA


PS Ratio Performance Analysis for SANOFI INDIA

- SANOFI INDIA 's latest p/e ratio is 6.04x.

- SANOFI INDIA 's p/e ratio for fiscal years ending Dec2023 to Dec2019 averaged 5.87x.

- SANOFI INDIA 's operated at median p/e ratio of 6.14x from fiscal years ending March 2018 to 2022.

- Looking back at the last 5 fiscal years, SANOFI INDIA 's p/e ratio peaked in Dec2020 at 6.59x.

- SANOFI INDIA 's p/e ratio hit its five-year low in Dec2022 of 4.86x.


How does SANOFI INDIA 's P/S Ratio benchmark against top 10 peers in Pharmaceuticals & Drugs Industry?

Peer Comparison (Pharmaceuticals & Drugs Industry)Sales (Cr)PS RatioMarket Cap (Cr)
SANOFI INDIA 2,234.86.0413,500.9
SUN PHARMACEUTICAL INDUSTRIES LTD51,602.57.97411,306.0
DIVIS LABORATORIES LTD9,078.016.56150,343.0
CIPLA LTD26,981.24.35117,323.0
TORRENT PHARMACEUTICALS LTD11,302.09.61108,619.0
DR REDDYS LABORATORIES LTD31,229.33.0795,941.5
MANKIND PHARMA LTD11,641.08.5899,891.5
ZYDUS LIFESCIENCES LTD22,247.44.0389,680.6
LUPIN LTD22,001.64.1791,742.2
AUROBINDO PHARMA LTD30,921.82.1867,294.6
ABBOTT INDIA LTD6,243.210.0762,839.7

Pharmaceuticals & Drugs Industry Benchmark (Top 10) PS Analysis vs SANOFI INDIA 's P/S Ratio

Top 10 Industry PeersPS Ratio
Min industry PS 2.18x
Max industry PS 16.56x
Median industry PS 6.04x
Average industry PS 6.97x



You may also like the below Video Courses